Posts

New Nature Biotechnology Article Highlights the Need for Cell-Cell Interaction Data in AI Biology

on

Infinimmune Appoints Srikanth Pendyala, M.D., as Chief Medical Officer

on

Hemab Therapeutics Holdings Sets Terms for $200 Million IPO

on

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

on

Curve Biosciences Appoints Dr. Amit Singal as Chief Medical Officer

on

Immunic Appoints Jon Congleton to Board of Directors

on

Infinity Bio Appoints Brian McKelligon as Chief Executive Officer

on

IsomAb Appoints Dr. Philip Brainin as Chief Executive Officer

on

Artiva Biotherapeutics Appoints Thad Huston as Chief Financial Officer

on

Pliant Therapeutics Q3 2025 Financial Results and Corporate Update

on

TECregen Appoints Dr. Klaas P. Zuideveld as CEO to Lead Thymus Regeneration Platform

on

Vera Therapeutics Appoints Matt Skelton as Chief Commercial Officer

on

Convergent Therapeutics Appoints Elizabeth L. Montgomery as Chief People Officer

on

Qlaris Bio Appoints Robert Warner to Board of Directors

on

Biogen Issues Statement Mourning Co-Founder Charles Weissmann's Passing

on

Specific Biologics Appoints Dr. Richard Glickman to Board of Directors

on

Ankyra Therapeutics Appoints Sailaja Battula, PhD as Chief Scientific Officer

on

Ansa Biotechnologies Appoints Geoff Hamilton as Chief Financial Officer and Chief Business Officer

on

Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional Investment

on

Nona Biosciences Appoints Dr. Hongjiang Miao as Chief AI Officer to Advance A³ Strategy and AI-Driven Drug Discovery

on